Preferred Label : hydroxyethyl starch derivatives;

MeSH definition : Starches that have been chemically modified so that a percentage of OH groups are substituted with 2-hydroxyethyl ether groups.;

MeSH synonym : derivatives, hydroxyethyl starch; starch derivatives, hydroxyethyl; starches, 2-Hydroxyethyl; 2-Hydroxyethyl starches; starches, 2 hydroxyethyl; hydroxyethylated starches; starches, hydroxyethylated;

CISMeF synonym : hydroxyethyl starch; starch, 2-hydroxyethyl ether; starch, hydroxyethyl; Bristol-Myers squibb brand of pentastarch; Rhône-Poulenc rorer brand of pentastarch; braun brand of pentastarch; fresenius brand of pentastarch; fresenius kabi brand of hydroxyethylstarch;

MeSH hyponym : pentaspan; pentastarch; hespan; plasmasteril; HAES-steril; hetastarch; elohes; pentafraction; hydroxyethyl starch 130-0.4; hemohes; Hydroxyethyl Starch 130 0.4; Hydroxyethyl Starch (130 KD-0.4 Substitution);

MeSH Related Number : hydroxyethyl starch 130-0.4; pentastarch; hetastarch; 1GVO236S58; 875Y4127EA; MOQ3RNM0SV;

Registry Number MeSH : 9005-27-0;

Related CAS MeSH : 1GVO236S58 (Hydroxyethyl starch 130-0.4); MOQ3RNM0SV (Pentastarch); 875Y4127EA (Hetastarch);

Wikipedia link : https://en.wikipedia.org/wiki/Hetastarch;

Is substance : O;

Details


Main resources

You can consult :

Starches that have been chemically modified so that a percentage of OH groups are substituted with 2-hydroxyethyl ether groups.

https://ansm.sante.fr/informations-de-securite/specialites-a-base-dhydroxyethylamidon-hea-v-suspension-des-autorisations-de-mise-sur-le-marche-amm
https://ansm.sante.fr/actualites/suspension-des-autorisations-de-mise-sur-le-marche-amm-des-medicaments-a-base-dhydroxyethylamidon
2022
false
false
false
France
French
pharmacovigilance note
Safety-Based drug withdrawals
hydroxyethyl starch derivatives
hydroxyethylstarch
plasma substitutes
infusions, intravenous
hypovolemia

---
https://ansm.sante.fr/informations-de-securite/solutions-pour-perfusion-a-base-dhydroxyethylamidon-hea-v-programme-dacces-controle-des-le-16-avril-2019
2019
false
false
false
France
French
drug information
accreditation
legislation, pharmacy
hydroxyethyl starch derivatives
hydroxyethylstarch
education, continuing
hydroxyethyl starch derivatives
product surveillance, postmarketing
risk management

---
https://ansm.sante.fr/actualites/solutions-pour-perfusion-a-base-dhydroxyethylamidon-hea-v-maintien-des-amm-sous-reserve-du-strict-respect-des-conditions-dutilisation
2018
false
false
false
false
France
French
pharmacovigilance note
guidelines for drug use
product surveillance, postmarketing
mortality, excess
sepsis
kidney diseases
hydroxyethyl starch derivatives
critical care
Contraindications, Drug
renal insufficiency
hypovolemia
guideline adherence
hydroxyethylstarch
plasma substitutes
mortality

---
https://www.hc-sc.gc.ca/dhp-mps/medeff/reviews-examens/hes-hea-fra.php
2015
false
false
false
Canada
French
English
drug evaluation
risk assessment
pharmacovigilance note
drug evaluation
canada
hydroxyethyl starch derivatives
hydroxyethylstarch
Hetastarch adverse reaction (disorder)
plasma substitutes
kidney diseases
hydroxyethyl starch derivatives
plasma substitutes
Contraindications, Procedure
Contraindications, Drug

---
http://www.has-sante.fr/portail/jcms/c_1777260/fr/voluven
http://www.has-sante.fr/portail/jcms/c_1777260/fr/voluven-hydroxyethylamidon-solutes-de-remplissage-colloide
http://www.has-sante.fr/portail/jcms/c_399173/fr/voluven-solution-pour-perfusion-500-ml-en-poche-pvc-de-type-perfuflex-suremballee-boite-de-1-poche
http://www.has-sante.fr/portail/jcms/c_400348/fr/voluven-solution-pour-perfusion-poche-de-500-ml-pvc-de-type-perfuflex-suremballee-cip-356-738-0
2014
false
true
false
France
French
evaluation of the transparency committee
drug combinations
sodium chloride
HES 130-0.4
plasma substitutes
infusions, intravenous
hydroxyethylstarch
treatment outcome
hypovolemia
Postoperative hypovolemic shock (disorder)
postoperative hemorrhage
guidelines for drug use
hydroxyethyl starch derivatives

---
http://www.has-sante.fr/portail/jcms/c_1777259/fr/restorvol
2014
true
France
French
postoperative hemorrhage
treatment outcome
Postoperative hypovolemic shock (disorder)
infusions, intravenous
drug combinations
sodium chloride
HES 130-0.4
hydroxyethyl starch derivatives
plasma substitutes
hypovolemia
hydroxyethylstarch
evaluation of the transparency committee

---
http://www.has-sante.fr/portail/jcms/c_1777265/fr/isovol
2014
false
false
false
France
French
evaluation of the transparency committee
infusions, intravenous
plasma substitutes
hypovolemia
hemorrhage
hydroxyethylstarch
drug combinations
sodium acetate
malic acid
calcium chloride
magnesium chloride
potassium chloride
sodium chloride
HES 130-0.4
postoperative complications
Postoperative hypovolemic shock (disorder)
malates
hydroxyethyl starch derivatives

---
https://healthycanadians.gc.ca/recall-alert-rappel-avis/hc-sc/2013/34697a-fra.php
2013
Canada
French
English
Contraindications, Procedure
hydroxyethyl starch derivatives
pharmacovigilance note
hydroxyethylstarch
plasma substitutes
infusions, intravenous
kidney diseases
death
hepatic insufficiency
hydroxyethyl starch derivatives
plasma substitutes
Contraindications, Drug

---
http://www.cochrane.org/fr/CD007594
2013
false
true
false
France
United Kingdom
kidney diseases
hydroxyethyl starch derivatives
review of literature
french abstract
hydroxyethyl starch derivatives

---
http://base-donnees-publique.medicaments.gouv.fr/extrait.php?specid=60900520
2013
summary of product characteristics
calcium chloride
potassium chloride
magnesium chloride
sodium acetate
hydroxyethyl starch derivatives
sodium chloride
malic acid
malic acid

---
https://healthycanadians.gc.ca/recall-alert-rappel-avis/hc-sc/2013/34299a-fra.php
2013
Canada
English
French
Contraindications, Procedure
critical care
hydroxyethyl starch derivatives
hydroxyethylstarch
pharmacovigilance note
plasma substitutes
sepsis
end stage liver disease
renal insufficiency
Contraindications, Drug

---
http://www.has-sante.fr/portail/jcms/c_834681/plasmavolume-6-hydroxyethylamidon-solution-de-ringer-solution-de-remplissage-vasculaire
http://www.has-sante.fr/portail/jcms/c_799852/plasmavolume-ct-6338
2009
France
French
hypovolemia
hydroxyethyl starch derivatives
plasma substitutes
isotonic solutions
drug combinations
hydroxyethylstarch
ringer's acetate
infusions, intravenous
evaluation of the transparency committee
guidelines for drug use

---
http://www.has-sante.fr/portail/jcms/c_798105/plasmavolume
http://www.has-sante.fr/portail/upload/docs/application/pdf/2009-05/plasmavolume_-_ct-6338.pdf
http://www.has-sante.fr/portail/upload/docs/application/pdf/2011-05/plasmavolume_ct_6338.pdf
2009
France
French
English
evaluation of the transparency committee
hydroxyethylstarch
plasma substitutes
treatment outcome
hydroxyethyl starch derivatives
ringer's acetate
isotonic solutions
infusions, intravenous
hypovolemia
shock

---
http://www.has-sante.fr/portail/jcms/c_812381/restorvol-6-hydroxyethylamidon
http://www.has-sante.fr/portail/jcms/c_677431/fr/restorvol
2008
false
France
French
infusions, intravenous
sodium chloride
HES 130-0.4
treatment outcome
drug combinations
hydroxyethyl starch derivatives
plasma substitutes
hypovolemia
hydroxyethylstarch
evaluation of the transparency committee
guidelines for drug use

---
https://pgtmsite.files.wordpress.com/2024/01/hydroxyethylamidon_pgtm_20071017.pdf
2007
Canada
drug information
hydroxyethyl starch derivatives
Hetastarch
hetastarch

---
http://www.has-sante.fr/portail/display.jsp?id=c_399874
http://www.has-sante.fr/portail/upload/docs/application/pdf/ct-031443_hyperhes.pdf
2003
France
French
drug combinations
sodium chloride
hydroxyethyl starch derivatives
plasma substitutes
hydroxyethylstarch
infusions, intravenous
hypovolemia
acute disease
evaluation of the transparency committee

---
Nous contacter.
24/05/2025


[Home] [Top]

© Rouen University Hospital. Any partial or total use of this material must mention the source.